Reciprocal induction of hepatitis C virus replication and stimulation of hepatic profibrogenic cytokine release and cellular viability by YKL-40

被引:4
作者
Cheng, Du [1 ]
Zhu, Chengliang [2 ]
Liao, Fei [1 ]
Zhao, Liang [1 ]
Shen, Lei [1 ]
Jiang, Wenyang [3 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Hubei Key Lab Digest Dis, Wuhan 430060, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Dept Thorac Surg, Wuhan 430060, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatitis C virus (HCV); YKL-40; tumor necrosis factor-alpha (TNF-alpha); nuclear factor-kappa B (NF-kappa B); fibrosis; SERUM FIBROSIS MARKERS; NF-KAPPA-B; LIVER-DISEASE PROGRESSION; HYALURONIC-ACID; INFLAMMATORY CYTOKINES; NONINVASIVE MARKERS; HCV INFECTION; TRANSPLANTATION; EXPRESSION;
D O I
10.21037/atm-21-4537
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Previous studies have suggested the YKL-40/chitinase 3-like protein 1 protein is upregulated in chronic hepatitis C virus (HCV) infection with fibrosis. We sought to determine whether HCV regulates YKL-40 expression and to elucidate the mechanisms by which YKL-40 mediates the liver fibrosis caused by HCV infection. Methods: We used purified protein, small molecule inhibitors and short-interfering RNAs to over-express or knock down certain kinases to explore the mechanisms underlying the regulation by HCV of YKL-40 expression in the Japanese fulminant hepatitis 1 (JFH1) model. Results: HCV induced YKL-40 production in hepatic parenchymal cells. Further, HCV-mediated upregulation of YKL-40 through cooperative induction of tumor necrosis factor-alpha (TNF-alpha) and reactive oxygen species (ROS)-mitogen-activated protein kinase MAPKs, which are nuclear factor-kappa B (NF-kappa B)-dependent pathways. YKL-40 protein also mildly increased HCV replication, triggering hepatic profibrogenic cytokine release and cellular viability as feedback. Additionally, hepatic parenchymal cells were the sole source of YKL-40 production in the infectious JFH1 model, whereas YKL-40 was under-detected in hepatic stellate cells (HSCs) in the presence or absence of the JFH1 supernatant, which was not investigated so far. Conclusions: HCV induced and maintained secretion of YKL-40 through sustained activation of NF-kappa B via cooperative induction of the TNF-alpha and ROS-MAPKs pathways. HCV interacted with YKL-40 to enhance the progression of hepatic fibrosis. These findings support a potential role for blockade of YKL-40 as an antifibrotic strategy.
引用
收藏
页数:12
相关论文
共 32 条
[1]   Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment [J].
Bartels, Doug J. ;
Sullivan, James C. ;
Zhang, Eileen Z. ;
Tigges, Ann M. ;
Dorrian, Jennifer L. ;
De Meyer, Sandra ;
Takemoto, Darin ;
Dondero, Elizabeth ;
Kwong, Ann D. ;
Picchio, Gaston ;
Kieffer, Tara L. .
JOURNAL OF VIROLOGY, 2013, 87 (03) :1544-1553
[2]   Hepatitis C virus NS5A drives a PTEN-PI3K/Akt feedback loop to support cell survival [J].
Cheng, Du ;
Zhang, Leiliang ;
Yang, Guangbo ;
Zhao, Lei ;
Peng, Feng ;
Tian, Yi ;
Xiao, Xinqiang ;
Chung, Raymond T. ;
Gong, Guozhong .
LIVER INTERNATIONAL, 2015, 35 (06) :1682-1691
[3]   p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K-Akt pathways [J].
Cheng, Du ;
Zhao, Lei ;
Zhang, Leiliang ;
Jiang, Yongfang ;
Tian, Yi ;
Xiao, Xinqiang ;
Gong, Guozhong .
JOURNAL OF GENERAL VIROLOGY, 2013, 94 :326-335
[4]   Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection [J].
Chung, Raymond T. ;
Ghany, Marc G. ;
Kim, Arthur Y. ;
Marks, Kristen M. ;
Naggie, Susanna ;
Vargas, Hugo E. ;
Aronsohn, Andrew I. ;
Bhattacharya, Debika ;
Broder, Tina ;
Falade-Nwulia, O. ;
Fontana, Robert J. ;
Gordon, Stuart C. ;
Heller, Theo ;
Holmberg, Scott D. ;
Jhaveri, Ravi ;
Jonas, Maureen M. ;
Kiser, Jennifer J. ;
Linas, Benjamin P. ;
Lo Re, Vincent, III ;
Morgan, Timothy R. ;
Nahass, Ronald G. ;
Peters, Marion G. ;
Reddy, K. Rajender ;
Reynolds, Andrew ;
Scott, John D. ;
Searson, Gloria ;
Swan, Tracy ;
Terrault, Norah A. ;
Trooskin, Stacey B. ;
Wong, John B. ;
Workowski, Kimberly A. .
CLINICAL INFECTIOUS DISEASES, 2018, 67 (10) :1477-1492
[5]   Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo [J].
De Minicis, S. ;
Candelaresi, C. ;
Marzioni, M. ;
Saccomano, S. ;
Roskams, T. ;
Casini, A. ;
Risaliti, A. ;
Salzano, R. ;
Cautero, N. ;
di Francesco, F. ;
Benedetti, A. ;
Svegliati-Baroni, G. .
GUT, 2008, 57 (03) :352-364
[6]   Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C [J].
Esmat, Gamal ;
Metwally, Mohamed ;
Zalata, Khalid R. ;
Gadalla, Shahinaz ;
Abdel-Hamid, Mohamed ;
Abouzied, Amr ;
Shaheen, Abdel-Aziz ;
El-Raziky, Maissa ;
Khatab, Hani ;
El-Kafrawy, Sherif ;
Mikhail, Nabiel ;
Magder, Laurence S. ;
Afdhal, Nezam H. ;
Strickland, G. Thomas .
JOURNAL OF HEPATOLOGY, 2007, 46 (04) :620-627
[7]   Association between IL28B polymorphism and treatment response in patients with genotype 4 chronic hepatitis C [J].
Staettermayer, Albert Friedrich ;
Hofer, Harald ;
Ferenci, Peter .
JOURNAL OF HEPATOLOGY, 2012, 57 (03) :706-706
[8]   YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease [J].
Eurich, Dennis ;
Neumann, Ulf P. ;
Boas-Knoop, Sabine ;
Neuhaus, Ruth ;
Kiessling, Anja ;
Yahyazadeh, Ali ;
Trautwein, Christian ;
Wasmuth, Hermann ;
Puhl, Gero ;
Neuhaus, Peter ;
Bahra, Marcus .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) :153-160
[9]   A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers [J].
Faibish, Michael ;
Francescone, Ralph ;
Bentley, Brooke ;
Yan, Wei ;
Shao, Rong .
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (05) :742-751
[10]   Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C [J].
Fontana, Robert J. ;
Goodman, Zachary D. ;
Dienstag, Jules L. ;
Bonkovsky, Herbert L. ;
Naishadham, Deepa ;
Sterling, Richard K. ;
Su, Grace L. ;
Ghosh, Mita ;
Wright, Elizabeth C. .
HEPATOLOGY, 2008, 47 (03) :789-798